您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2016, Vol. 54 ›› Issue (7): 6-10.doi: 10.6040/j.issn.1671-7554.0.2015.1247

• • 上一篇    下一篇

ARNT2在胃癌中的表达及临床意义

郝姝桦,郏雁飞,郑燕,马晓丽,孔毅,黎娉,宗帅,张垚,汪运山   

  1. 山东大学附属济南市中心医院中心实验室, 山东 济南 250013
  • 收稿日期:2015-12-07 出版日期:2016-07-10 发布日期:2016-07-10
  • 通讯作者: 汪运山. E-mail:sdjnwys@163.com E-mail:sdjnwys@163.com
  • 基金资助:
    国家自然科学基金(810008869,81272588);国家重点基础研究发展计划(973计划)(2012CB966503,2012CB966504);山东省自然科学基金(ZR2015HM018,ZR2012HM061);山东省优秀中青年科学家科研奖励基金(BS2011YY039)

Expression and clinical significance of ARNT2 in gastric carcinoma

HAO Shuhua, JIA Yanfei, ZHENG Yan, MA Xiaoli, KONG Yi, LI Ping, ZONG Shuai, ZHANG Yao, WANG Yunshan   

  1. Central Laboratory, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, China
  • Received:2015-12-07 Online:2016-07-10 Published:2016-07-10

PDF (PC)

628

摘要： 目的 探讨人胃癌中芳香烃受体核易位蛋白2(ARNT2)的表达及临床意义。 方法 运用qRT-PCR和Western blotting检测ARNT2在正常胃细胞株及多种胃癌细胞株中的表达。通过免疫组织化学检测61例胃癌组织及相应癌旁胃黏膜组织中ARNT2的表达。 结果 ARNT2 mRNA和蛋白在胃癌细胞株中的表达水平显著低于正常胃细胞株。胃癌组织中ARNT2的阳性表达率显著低于癌旁胃黏膜组织(32.79% vs 80.33%,P<0.05),与细胞株的检测结果一致。并且,胃癌中ARNT2的表达水平与肿瘤的分化程度显著相关(P<0.05)。 结论 ARNT2在胃癌细胞及组织中低表达,并且其表达水平与胃癌的分化程度相关,提示其可能参与胃癌的发生与发展。

关键词: 转录因子, 胃癌, 芳香烃受体核易位蛋白2

Abstract: Objective To investigate the expression of aryl hydrocarbon receptor nuclear translocator 2(ARNT2)in human gastric carcinoma and its clinical significance. Methods The mRNA and protein expression levels of ARNT2 in normal gastric cell line and several gastric cancer cell lines were measured by quantitative real-time reverse transcription-polymerase chain reaction(qRT-PCR)and Western blotting. The expressions of ARNT2 protein in 61 cases of gastric cancer tissues and adjacent non-tumor tissues were detected by immunohistochemistry. Results The mRNA and protein expressions of ARNT2 in gastric cancer cell lines were significantly lower than those in normal gastric cell line. The positive expression of ARNT2 in gastric cancer tissues was lower than that in adjacent non-tumor tissues(32.79% vs 80.33%, P<0.05). Furthermore, ARNT2 expression was closely correlated with the differentiation of gastric cancer(P<0.05). Conclusion The expression of ARNT2 is lower in gastric cancer cells and tissues than in non-tumor cells and tissues, and is correlated with the differentiation of gastric cancer, which suggests that ARNT2 may participate in the occurrence and development of gastric cancer.

Key words: Gastric carcinoma, Aryl hydrocarbon receptor nuclear translocator 2, Transcription factor

中图分类号: 

  • R735.2
[1] Bersten DC, Sullivan AE, Peet DJ, et al. bHLH-PAS proteins in cancer[J]. Nat Rev Cancer, 2013, 13(12): 827-841.
[2] Hirose K, Morita M, Ema M, et al. cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor(Arnt2)with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator(Arnt)[J]. Mol Cell Biol, 1996, 16(4): 1706-1713.
[3] Reyes H, Reisz-Porszasz S, Hankinson O. Identification of the Ah receptor nuclear translocator protein(Arnt)as a component of the DNA binding form of the Ah receptor[J]. Science, 1992, 256(5060): 1193-1195.
[4] Drutel G, Kathmann M, Heron A, et al. Cloning and selective expression in brain and kidney of ARNT2 homologous to the Ah receptor nuclear translocator(ARNT)[J]. Biochem Biophy Res Commun, 1996, 225(2): 333-339.
[5] Aitola MH, Pelto-Huikko MT. Expression of Arnt and Arnt2 mRNA in developing murine tissues[J]. J Histochem Cytochem, 2003, 51(1): 41-54.
[6] Hankinson O. Why does ARNT2 behave differently from ARNT?[J]. Toxicol Sci, 2008, 103(1): 1-3.
[7] Qin XY, Wei F, Yoshinaga J, et al. siRNA-mediated knockdown of aryl hydrocarbon receptor nuclear translocator 2 affects hypoxia-inducible factor-1 regulatory signaling and metabolism in human breast cancer cells[J]. FEBS lett, 2011, 585(20): 3310-3315.
[8] Martinez V, Kennedy S, Doolan P, et al. Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue[J]. Breast Cancer Res Treat, 2008, 110(3): 521-530.
[9] Yang B, Yang E, Liao H, et al. ARNT2 is downregulated and serves as a potential tumor suppressor gene in non-small cell lung cancer[J]. Tumour Biol, 2015, 36(3): 2111-2119.
[10] Li W, Liang Y, Yang B, et al. Downregulation of ARNT2 promotes tumor growth and predicts poor prognosis in human hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2015, 30(6): 1085-1093.
[11] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
[12] 邹文斌, 李兆申. 中国胃癌发病率及死亡率研究进展[J]. 中国实用内科杂志, 2014, 34(4): 408-415.
[13] Keith B, Adelman DM, Simon MC. Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2(Arnt2)gene reveals partial redundancy with Arnt[J]. Proc Natl Acad Sci USA, 2001, 98(12): 6692-6697.
[14] Sribudiani Y, Metzger M, Osinga J, et al. Variants in RET associated with Hirschsprungs disease affect binding of transcription factors and gene expression[J]. Gastroenterology, 2011, 140(2): 572-582 e2. doi: 10.1053/j.gastro.2010.10.044.
[15] Zudaire E, Cuesta N, Murty V, et al. The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers[J]. J Clin Invest, 2008, 118(2): 640-650.
[16] Qin XY, Wei F, Yoshinaga J, et al. siRNA-mediated knockdown of aryl hydrocarbon receptor nuclear translocator 2 affects hypoxia-inducible factor-1 regulatory signaling and metabolism in human breast cancer cells[J]. FEBS lett, 2011, 585(20): 3310-3315.
[17] Garritano S, Inga A, Gemignani F, et al. More targets, more pathways and more clues for mutant p53[J]. Oncogenesis, 2013, 2: e54. doi: 10.1038/oncsis.2013.15.
[1] 张洁,赵颖慧,董雅琪,李娟,李培龙,杜鲁涛. GPR133基因甲基化在早期胃癌淋巴结转移预测中的作用[J]. 山东大学学报 (医学版), 2025, 63(3): 76-84.
[2] 陈文亮,王欢欢,郝金锦,弓蕊,赵强,张飞,高磊,董静逊. lncRNA PVT1表达在胃癌预后评估及恶性进展中的作用:基于列线图模型与细胞功能实验的研究[J]. 山东大学学报 (医学版), 2025, 63(10): 61-71.
[3] 郝晓梦,于泽源,张晓芳. 肺胃型黏液腺癌具有独特的临床病理特征[J]. 山东大学学报 (医学版), 2024, 62(8): 107-116.
[4] 郭振江,王宁,赵光远,杜立强,崔朝勃,刘防震. 基于机器学习建立术前预测近端胃癌食管切缘阳性模型[J]. 山东大学学报 (医学版), 2024, 62(7): 78-83.
[5] 郭鑫,孟君,郑世良,董秀红. 老年胃癌患者衰弱与人体成分的相关性[J]. 山东大学学报 (医学版), 2024, 62(4): 40-47.
[6] 孙菁果,朱文帅,鲁艺,马晓丽,郏雁飞. 幽门螺杆菌感染对胃癌细胞m6A水平的影响及其机制[J]. 山东大学学报 (医学版), 2023, 61(9): 10-18.
[7] 樊荣,李彬彬,马晓丽,汪运山,郏雁飞. 胃癌中DEC2、HIF-2α的表达及临床意义[J]. 山东大学学报 (医学版), 2023, 61(7): 12-18.
[8] 穆彦熹,李金洲,陈康,梁红英,姚亚龙,汪文杰,陈晓. 443例胃癌根治术后发生肺部并发症的危险因素[J]. 山东大学学报 (医学版), 2023, 61(4): 37-41.
[9] 郭崇勇,赵朋,刘海盟,王强, 贾宗师,张建. 胸前丘疹为首发表现的胃癌1例[J]. 山东大学学报 (医学版), 2023, 61(4): 119-120.
[10] 王赞,徐晓涵,张瑜,曲业敏,王明义,陈艾. 幽门螺杆菌感染对胃癌细胞糖酵解的影响[J]. 山东大学学报 (医学版), 2023, 61(2): 16-24.
[11] 付佳,王路路,胡帅,陈哲平,刘东义,李青松,卢国栋,张贺,赵鑫,冯昌. 不同入路腰方肌阻滞对胃癌根治患者术后恢复的影响[J]. 山东大学学报 (医学版), 2022, 60(8): 50-57.
[12] 包舒晴,杨明月,刘端瑞,汪运山,郏雁飞. NOX4在幽门螺旋杆菌诱导胃癌细胞ROS中的作用[J]. 山东大学学报 (医学版), 2022, 60(6): 19-25.
[13] 王景,谢艳,李培龙,杜鲁涛,王传新. GZMB基因cg16212145位点的异常甲基化芯片测定对胃癌早筛的价值[J]. 山东大学学报 (医学版), 2022, 60(6): 26-34.
[14] 高惠茹,杜甜甜,王允山,杜鲁涛,王传新. 基于单细胞转录组测序数据分析胃癌调节性T细胞特征[J]. 山东大学学报 (医学版), 2022, 60(5): 43-49.
[15] 穆彦熹,汪文杰,陈康,姚亚龙,李金洲,魏浩旗,刘海鹏,黄泽平,陈晓. 探寻一家系短期3例胃癌的临床病理及其相关肿瘤特征[J]. 山东大学学报 (医学版), 2022, 60(11): 96-101.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发